Illness management and recovery (IMR) in Danish community mental health centres

Helle Stentoft Dalum, Lisa Korsbek, John Hagel Mikkelsen, Karin Thomsen, Kristen Kistrup, Mette Olander, Jane Lindschou Hansen, Merete Nordentoft, Lene Falgaard Eplov, Helle Stentoft Dalum, Lisa Korsbek, John Hagel Mikkelsen, Karin Thomsen, Kristen Kistrup, Mette Olander, Jane Lindschou Hansen, Merete Nordentoft, Lene Falgaard Eplov

Abstract

Background: Schizophrenia and bipolar disorder are severe mental illnesses that can have a significant disabling impact on the lives of people. Psychosocial interventions that stress hope and recovery as a part of a multi-dimensional approach are possibly indicated to support people with severe mental illness in facilitating recovery. Illness Management and Recovery (IMR) is a curriculum-based psychosocial intervention designed as structured program with a recovery-oriented approach. The aim of IMR is to rehabilitate people with severe mental illnesses by helping them acquire knowledge and skills in managing their illness and achieve personal recovery goals. Previous randomised clinical trials indicate that IMR can be implemented with a good effect and a high fidelity though further trials are crucial to demonstrate the potential effectiveness of IMR.

Methods/design: The trial design is a randomised, assessor-blinded, multi-centre, clinical trial of the IMR program compared with treatment as usual for 200 participants diagnosed with schizophrenia or bipolar disorder under the care of two community mental health centres in the Capital Region of Denmark. The primary outcome is level of functioning at the end of treatment. The secondary outcomes are disease symptoms; use of alcohol/drugs; individual meaning of recovery; hope; hospital admissions and out-patient psychiatric treatment at the end of treatment and the abovementioned and level of functioning at follow-up 21 months after baseline.

Discussion: If the results of this trial show IMR to be effective these positive results will strengthen the evidence of IMR as an effective comprehensive psychosocial intervention with a recovery-oriented approach for people with severe mental illness. This will have significant implications for the treatment and recovery of people with severe mental illness.

Trial registration: ClinicalTrials.gov NCT01361698.

Figures

Figure 1
Figure 1
The theoretical foundation for Illness Management and Recovery. The trans-theoretical model and the stress-vulnerability model are the theoretical underpinning of the IMR program.

References

    1. Kopelowicz A, Liberman RP. Integrating treatment with rehabilitation for persons with major mental illnesses. Psychiatr Serv. 2003;54:1491–1498. doi: 10.1176/appi.ps.54.11.1491.
    1. Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, Himelhoch S, Fang B, Peterson E, Aquino P, Keller W. The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements. Schizophr Bull. 2010;36:71–93. doi: 10.1093/schbul/sbp116.
    1. Harrison G, Hopper K, Craig T, Laska E, Siegel C, Wanderling J, Dube KC, Ganev K, Giel R, an der Heiden W, Holmberg SK, Janca A, Lee PW, Leon CA, Malhotra S, Marsella AJ, Nakane Y, Sartorius N, Shen Y, Skoda C, Thara R, Tsirkin SJ, Varma VK, Walsh D, Wiersma D. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry. 2001;178:506–517. doi: 10.1192/bjp.178.6.506.
    1. Hopper K, Janca A, Statorius N. In: A Report from the WHO Collaborative Project, the International Study of Schizophrenia. Statorius N, Hopper K, Janca A, editor. Oxford, Oxford Univerisity Press; 2007. Recovery from Schizophrenia: An International Perspective.
    1. Corrigan PW, Mueser KT, Bond GR, Drake RE, Solomon P. An empirical approach. New York, The Guilford Press; 2008. Principles and practice of psychiatric rehabilitation.
    1. Anthony WA. Recovery from mental illness: The guiding vision of the mental health service system in the 1990s. Psychosocial Rehabilitation Journal. 1993;16:11.
    1. Mueser KT, Corrigan PW, Hilton DW, Tanzman B, Schaub A, Gingerich S, Essock SM, Tarrier N, Morey B, Vogel-Scibilia S, Herz MI. Illness management and recovery: a review of the research. Psychiatr Serv. 2002;53:1272–1284. doi: 10.1176/appi.ps.53.10.1272.
    1. Derisley J, Reynolds S. Evaluation of the Stages of Change Scales to Measure Client Readiness for Treatment in a Mental Health Sample. Behavioural and Cognitive Psychotherapy. 2002;30:217–222.
    1. Norcross JC, Krebs PM, Prochaska JO. Stages of change. J Clin Psychol. 2011;67:143–154. doi: 10.1002/jclp.20758.
    1. Goh C, Agius M. The stress-vulnerability model how does stress impact on mental illness at the level of the brain and what are the consequences? Psychiatr Danub. 2010;22:198–202.
    1. Das SK, Malhotra S, Basu D, Malhotra R. Testing the stress-vulnerability hypothesis in ICD-10-diagnosed acute and transient psychotic disorders. Acta Psychiatr Scand. 2001;104:56–58.
    1. Bartholomew T, Kensler D. Illness Management and Recovery in State Psychiatric Hospitals. American Journal of Psychiatric Rehabilitation. 2010;13:105–125. doi: 10.1080/15487761003756977.
    1. Fujita E, Kato D, Kuno E, Suzuki Y, Uchiyama S, Watanabe A, Uehara K, Hirayasu Y. Implementing the illness management and recovery program in Japan. Psychiatr Serv. 2010;61:1157–1161. doi: 10.1176/appi.ps.61.11.1157.
    1. Roe D, Hasson-Ohayon I, Salyers MP, Kravetz S. A one year follow-up of illness management and recovery: participants' accounts of its impact and uniqueness. Psychiatr Rehabil J. 2009;32:285–291. doi: 10.2975/32.4.2009.285.291.
    1. Salyers MP, McGuire AB, Rollins AL, Bond GR, Mueser KT, Macy VR. Integrating assertive community treatment and illness management and recovery for consumers with severe mental illness. Community Ment Health J. 2010;46:319–329. doi: 10.1007/s10597-009-9284-6.
    1. Levitt AJ, Mueser KT, Degenova J, Lorenzo J, Bradford-Watt D, Barbosa A, Karlin M, Chernick M. Randomized controlled trial of illness management and recovery in multiple-unit supportive housing. Psychiatr Serv. 2009;60:1629–1636. doi: 10.1176/appi.ps.60.12.1629.
    1. Hasson-Ohayon I, Roe D, Kravetz S. A randomized controlled trial of the effectiveness of the illness management and recovery program. Psychiatr Serv. 2007;58:1461–1466. doi: 10.1176/appi.ps.58.11.1461.
    1. Fardig R, Lewander T, Melin L, Folke F, Fredriksson A. A randomized controlled trial of the illness management and recovery program for persons with schizophrenia. Psychiatr Serv. 2011;62:606–612. doi: 10.1176/appi.ps.62.6.606.
    1. Salyers MP, Rollins AL, McGuire AB, Gearhart T. Barriers and facilitators in implementing illness management and recovery for consumers with severe mental illness: trainee perspectives. Adm Policy Ment Health. 2009;36:102–111. doi: 10.1007/s10488-008-0200-0.
    1. Salyers MP, Godfrey JL, McGuire AB, Gearhart T, Rollins AL, Boyle C. Implementing the illness management and recovery program for consumers with severe mental illness. Psychiatr Serv. 2009;60:483–490. doi: 10.1176/appi.ps.60.4.483.
    1. Mueser KT, Meyer PS, Penn DL, Clancy R, Clancy DM, Salyers MP. The Illness Management and Recovery program: rationale, development, and preliminary findings. Schizophr Bull. 2006;32(Suppl 1):S32–S43.
    1. Gingerich S, Mueser KT. Illness Management and Recovery. Rockville, Md, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services; 2003.
    1. Piersma HL, Boes JL. The GAF and psychiatric outcome: a descriptive report. Community Ment Health J. 1997;33:35–41. doi: 10.1023/A:1022413110345.
    1. Pedersen G, Hagtvet KA, Karterud S. Generalizability studies of the Global Assessment of Functioning-Split version. Compr Psychiatry. 2007;48:88–94. doi: 10.1016/j.comppsych.2006.03.008.
    1. Davidson L, Schmutte T, Dinzeo T, Andres-Hyman R. Remission and recovery in schizophrenia: practitioner and patient perspectives. Schizophr Bull. 2008;34:5–8.
    1. Slade M, Amering M, Oades L. Recovery: an international perspective. Epidemiol Psichiatr Soc. 2008;17:128–137.
    1. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261–276.
    1. Daneluzzo E, Arduini L, Rinaldi O, Di DM, Petruzzi C, Kalyvoka A, Rossi A. PANSS factors and scores in schizophrenic and bipolar disorders during an index acute episode: a further analysis of the cognitive component. Schizophr Res. 2002;56:129–136. doi: 10.1016/S0920-9964(01)00277-8.
    1. Lecrubier Y, Bech P. The Ham D(6) is more homogenous and as sensitive as the Ham D(17) Eur Psychiatry. 2007;22:252–255. doi: 10.1016/j.eurpsy.2007.01.1218.
    1. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–435. doi: 10.1192/bjp.133.5.429.
    1. Burns T, Patrick D. Social functioning as an outcome measure in schizophrenia studies. Acta Psychiatr Scand. 2007;116:403–418. doi: 10.1111/j.1600-0447.2007.01108.x.
    1. Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R. Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand. 2000;101:323–329.
    1. Salyers MP, Godfrey JL, Mueser KT, Labriola S. Measuring illness management outcomes: a psychometric study of clinician and consumer rating scales for illness self management and recovery. Community Ment Health J. 2007;43:459–480. doi: 10.1007/s10597-007-9087-6.
    1. Young SL, Ensing DS, Bullock WA. In: Can we measure recovery? A compendium of recovery-related instruments. Ralph RO, Kidder K, Phillips D, editor. Cambridge, MA, The evaluation center @ HSRI; 2000. Mental Health Recovery Measure.
    1. Snyder CR, Sympson SC, Ybasco FC, Borders TF, Babyak MA, Higgins RL. Development and validation of the State Hope Scale. J Pers Soc Psychol. 1996;70:321–335.
    1. Fukui S, Starnino VR, Susana M, Davidson LJ, Cook K, Rapp CA, Gowdy EA. Effect of Wellness Recovery Action Plan (WRAP) participation on psychiatric symptoms, sense of hope, and recovery. Psychiatr Rehabil J. 2011;34:214–222. doi: 10.2975/34.3.2011.214.222.
    1. Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2:197–207. doi: 10.1016/0149-7189(79)90094-6.
    1. Merinder LB, Viuff AG, Laugesen HD, Clemmensen K, Misfelt S, Espensen B. Patient and relative education in community psychiatry: a randomized controlled trial regarding its effectiveness. Soc Psychiatry Psychiatr Epidemiol. 1999;34:287–294. doi: 10.1007/s001270050146.
    1. Haddock G, Barrowclough C, Tarrier N, Morning J, O'Brien R, Schofield N, Quinn J, Palmer S, Davies L, Lowens I, McGovern J, Lewis S. Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18-month outcomes of a randomised controlled trial+. [Article] Br J Psychiatry. 2003;183:418–426. doi: 10.1192/bjp.183.5.418.
    1. Dupont WD, Plummer WD Jr. Power and sample size calculations for studies involving linear regression. Control Clin Trials. 1998;19:589–601. doi: 10.1016/S0197-2456(98)00037-3.
    1. Dickerson FB, Sommerville J, Origoni AE, Ringel NB, Parente F. Outpatients with schizophrenia and bipolar I disorder: Do they differ in their cognitive and social functioning? Psychiatry Res. 2001;102:21–27. doi: 10.1016/S0165-1781(01)00247-5.
    1. Laes JR, Sponheim SR. Does cognition predict community function only in schizophrenia?: a study of schizophrenia patients, bipolar affective disorder patients, and community control subjects. Schizophr Res. 2006;84:121–131. doi: 10.1016/j.schres.2005.11.023.
    1. Tabares-Seisdedos R, Balanza-Martinez V, Sanchez-Moreno J, Martinez-Aran A, Salazar-Fraile J, Selva-Vera G, Rubio C, Mata I, Gomez-Beneyto M, Vieta E. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. J Affect Disord. 2008;109:286–299. doi: 10.1016/j.jad.2007.12.234.
    1. Simonsen C, Sundet K, Vaskinn A, Ueland T, Romm KL, Hellvin T, Melle I, Friis S, Andreasson OA. Psychosocial function in schizophrenia and bipolar disorder: Relationship to neurocognition and clinical symptoms. J Int Neuropsychol Soc. 2010;16:771–783. doi: 10.1017/S1355617710000573.
    1. Miklowitz DJ, Otto MW, Frank E, Reilly-Harrington NA, Kogan JN, Sachs GS, Thase ME, Calabrese JR, Marangell LB, Ostacher MJ, Patel J, Thomas MR, Araga M, Gonzales JM, Wiesniewski SR. Intensive Psychosocial Intervention Enhances Functioning in Patients With Bipolar Depression: Results From a 9-Month Randomized Controlled Trial. Am J Psychiatry. 2007;164:1340–1347. doi: 10.1176/appi.ajp.2007.07020311.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi